NCT01711554 2026-03-18Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent NeuroblastomaNational Cancer Institute (NCI)Phase 1 Active not recruiting27 enrolled